Loading investment pitches...
Equity Research Database
Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
AstraZeneca is one of the largest pharmaceutical companies in the world. It researches, develops...
— David G. Herro, Tony Coniaris, Eric Liu, M. Colin Hudson, John A. Sitarz
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on AstraZeneca PLC
No other institutional pitches found for this ticker yet.
More institutional theses from Oakmark Global Fund
IQVIA Holdings ($IQV), representing 3.3% of the fund's net assets, is a leading global provider of advanced data analytics, clinical research services, and technology infrastructure to life sciences and biopharmaceutical enterprises. The manager holds...
DSV A/S ($DSV.CO), which accounts for 2.6% of portfolio assets, is a Danish global transport and logistics giant offering freight forwarding across road, air, sea, and contract warehousing. The manager maintains...
Meta Platforms ($META) is a new portfolio purchase representing 1.9% of fund assets. The digital advertising...